Practical recommendations for the prevention and management of COVID-19 in low-income and middle-income settings: adapting clinical experience from the field

Sasha Abdallah Fahme; Kathleen F Walsh; Vanessa Rouzier; Puja Chebrolu; Hyasinta Jaka; Justin Roy Kingery; Fouad M Fouad; Jyoti S Mathad; Jennifer A Downs; Margaret McNairy

doi:10.1136/fmch-2021-000930

Fahme, Sasha Abdallah; Walsh, Kathleen F; Rouzier, Vanessa; Chebrolu, Puja; Jaka, Hyasinta; Kingery, Justin Roy; Fouad, Fouad M; Mathad, Jyoti S; Downs, Jennifer A; McNairy, Margaret

2021-04-02 00:00:00

Open access Commentary Practical recommendations for the prevention and management of COVID-19 in low-income and middle- income settings: adapting clinical experience from the field 1,2 1,3 1,3 Sasha Abdallah Fahme , Kathleen F Walsh , Vanessa Rouzier, 1 4 1,4 5 Puja Chebrolu , Hyasinta Jaka, Justin Roy Kingery, Fouad M Fouad, 1 1,4 1,3 Jyoti S Mathad, Jennifer A Downs, Margaret McNairy To cite: Fahme SA, Walsh KF, government- mandated social distancing INTRODUCTION Rouzier V, et al. Practical measures were delayed by nearly 2 weeks Efforts to contain and respond to the novel recommendations for the following the first confirmed case of COVID-19 in both high-income and low- prevention and management COVID-19 on 3 March 2020, after which 5072 income countries remain extremely chal- of COVID-19 in low- income more were diagnosed. Emphasis on preven- and middle- income settings: lenging. Resource- constrained countries face adapting clinical experience tion should be placed with all the more the additional obstacles of limited health infra- from the field. Fam Med Com urgency in resource-limited countries. LMICs structure and inability to socially distance due Health 2021;9:e000930. have a rich history of robust prevention inter- to crowded and often multigenerational living doi:10.1136/fmch-2021-000930 ventions, community partnerships and educa-

http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png

Family Medicine and Community Health British Medical Journal

http://www.deepdyve.com/lp/british-medical-journal/practical-recommendations-for-the-prevention-and-management-of-covid-NKbvQdTLAF

Practical recommendations for the prevention and management of COVID-19 in low-income and middle-income settings: adapting clinical experience from the field

Fahme, Sasha Abdallah; Walsh, Kathleen F; Rouzier, Vanessa; Chebrolu, Puja; Jaka, Hyasinta;

Family Medicine and Community Health , Volume 9 (2) – Apr 2, 2021

Abstract

References (125)

(2020)

COVID-19) update: FDA authorizes monoclonal antibodies for treatment of COVID-19

M. Sjoding, R. Dickson, T. Iwashyna, S. Gay, T. Valley (2020)

Racial Bias in Pulse Oximetry Measurement.

The New England journal of medicine, 383 25

(Tobin MJ. Basing respiratory management of COVID-19 on physiological principles. Am J Respir Crit Care Med 2020;201:1319–20. 10.1164/rccm.202004-1076ED32281885)

Tobin MJ. Basing respiratory management of COVID-19 on physiological principles. Am J Respir Crit Care Med 2020;201:1319–20. 10.1164/rccm.202004-1076ED32281885

Tobin MJ. Basing respiratory management of COVID-19 on physiological principles. Am J Respir Crit Care Med 2020;201:1319–20. 10.1164/rccm.202004-1076ED32281885, Tobin MJ. Basing respiratory management of COVID-19 on physiological principles. Am J Respir Crit Care Med 2020;201:1319–20. 10.1164/rccm.202004-1076ED32281885

Sepsis Bulletin (2020)

Surviving Sepsis Campaign : Guidelines on the Management of Critically Ill Adults with Coronavirus Disease

(2020)

Nine out of 10 in poor nations to miss out on inoculation as West buys up Covid vaccines

N. Caputo, R. Strayer, R. Levitan (2020)

Early Self‐Proning in Awake, Non‐intubated Patients in the Emergency Department: A Single ED’s Experience During the COVID‐19 Pandemic

Academic Emergency Medicine, 27

Xueting Yao, F. Ye, Miao Zhang, Cheng Cui, Baoying Huang, P. Niu, X. Liu, Li Zhao, Erdan Dong, Chunli Song, S. Zhan, R. Lu, Haiyan Li, W. Tan, Dongyang Liu (2020)

In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America

(FDA. Coronavirus (COVID-19) update: FDA authorizes monoclonal antibodies for treatment of COVID-19, 2020.)

FDA. Coronavirus (COVID-19) update: FDA authorizes monoclonal antibodies for treatment of COVID-19, 2020.

FDA. Coronavirus (COVID-19) update: FDA authorizes monoclonal antibodies for treatment of COVID-19, 2020., FDA. Coronavirus (COVID-19) update: FDA authorizes monoclonal antibodies for treatment of COVID-19, 2020.

(Leung NHL, Chu DKW, Shiu EYC, et al. Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat Med 2020;26:676–80. 10.1038/s41591-020-0843-232371934)

Leung NHL, Chu DKW, Shiu EYC, et al. Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat Med 2020;26:676–80. 10.1038/s41591-020-0843-232371934

Leung NHL, Chu DKW, Shiu EYC, et al. Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat Med 2020;26:676–80. 10.1038/s41591-020-0843-232371934, Leung NHL, Chu DKW, Shiu EYC, et al. Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat Med 2020;26:676–80. 10.1038/s41591-020-0843-232371934

(2020)

An EUA for Bamlanivimab-A Monoclonal Antibody for COVID-19.

JAMA

M. Day (2020)

Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists

BMJ, 368

(Matharu GS, Kunutsor SK, Judge A, et al. Clinical effectiveness and safety of aspirin for venous thromboembolism prophylaxis after total hip and knee replacement: a systematic review and meta-analysis of randomized clinical trials. JAMA Intern Med 2020;180:376–84. 10.1001/jamainternmed.2019.610832011647)

Matharu GS, Kunutsor SK, Judge A, et al. Clinical effectiveness and safety of aspirin for venous thromboembolism prophylaxis after total hip and knee replacement: a systematic review and meta-analysis of randomized clinical trials. JAMA Intern Med 2020;180:376–84. 10.1001/jamainternmed.2019.610832011647, Matharu GS, Kunutsor SK, Judge A, et al. Clinical effectiveness and safety of aspirin for venous thromboembolism prophylaxis after total hip and knee replacement: a systematic review and meta-analysis of randomized clinical trials. JAMA Intern Med 2020;180:376–84. 10.1001/jamainternmed.2019.610832011647

(Mwai GW, Mburu G, Torpey K, et al. Role and outcomes of community health workers in HIV care in sub-Saharan Africa: a systematic review. J Int AIDS Soc 2013;16:18586. 10.7448/IAS.16.1.1858624029015)

Mwai GW, Mburu G, Torpey K, et al. Role and outcomes of community health workers in HIV care in sub-Saharan Africa: a systematic review. J Int AIDS Soc 2013;16:18586. 10.7448/IAS.16.1.1858624029015

Mwai GW, Mburu G, Torpey K, et al. Role and outcomes of community health workers in HIV care in sub-Saharan Africa: a systematic review. J Int AIDS Soc 2013;16:18586. 10.7448/IAS.16.1.1858624029015, Mwai GW, Mburu G, Torpey K, et al. Role and outcomes of community health workers in HIV care in sub-Saharan Africa: a systematic review. J Int AIDS Soc 2013;16:18586. 10.7448/IAS.16.1.1858624029015

(Gawande A. Keeping the coronavirus from infecting healthcare workers. The New Yorker, 2020.)

Gawande A. Keeping the coronavirus from infecting healthcare workers. The New Yorker, 2020.

Gawande A. Keeping the coronavirus from infecting healthcare workers. The New Yorker, 2020., Gawande A. Keeping the coronavirus from infecting healthcare workers. The New Yorker, 2020.

E. Padrão, F. Valente, B. Besen, Hassan Rahhal, Paula Mesquita, Julio Alencar, Millena Costa, Annelise Wanderley, D. Emerenciano, F. Bortoleto, Julio Fortes, Bruno Marques, Stefany Souza, Júlio Marchini, Rodrigo Neto, H. Souza (2020)

Awake Prone Positioning in COVID‐19 Hypoxemic Respiratory Failure: Exploratory Findings in a Single‐center Retrospective Cohort Study

Academic Emergency Medicine, 27

(Chow JH, Khanna AK, Kethireddy S, et al. Aspirin use is associated with decreased mechanical ventilation, intensive care unit admission, and in-hospital mortality in hospitalized patients with coronavirus disease 2019. Anesth Analg 2021;132:930–41. 10.1213/ANE.000000000000529233093359)

Chow JH, Khanna AK, Kethireddy S, et al. Aspirin use is associated with decreased mechanical ventilation, intensive care unit admission, and in-hospital mortality in hospitalized patients with coronavirus disease 2019. Anesth Analg 2021;132:930–41. 10.1213/ANE.000000000000529233093359, Chow JH, Khanna AK, Kethireddy S, et al. Aspirin use is associated with decreased mechanical ventilation, intensive care unit admission, and in-hospital mortality in hospitalized patients with coronavirus disease 2019. Anesth Analg 2021;132:930–41. 10.1213/ANE.000000000000529233093359

M. Borba, F. Val, V. Sampaio, M. Alexandre, G. Melo, M. Brito, Maria Mourão, Jose Sousa, D. Baía-da-Silva, M. Guerra, L. Hajjar, R. Pinto, A. Balieiro, F. Naveca, M. Xavier, A. Salomão, A. Siqueira, Alexandre Schwarzbolt, J. Croda, M. Nogueira, G. Romero, Q. Bassat, C. Fontes, B. Albuquerque, C. Daniel-Ribeiro, W. Monteiro, M. Lacerda (2020)

Chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (SARS-CoV-2) infection: Preliminary safety results of a randomized, double-blinded, phase IIb clinical trial (CloroCovid-19 Study)

medRxiv

(National Institutes of Health. COVID-19 treatment guidelines. Available: https://covid19treatmentguidelines.nih.gov/ [Accessed 23 Apr 2020].)

National Institutes of Health. COVID-19 treatment guidelines. Available: https://covid19treatmentguidelines.nih.gov/ [Accessed 23 Apr 2020].

National Institutes of Health. COVID-19 treatment guidelines. Available: https://covid19treatmentguidelines.nih.gov/ [Accessed 23 Apr 2020]., National Institutes of Health. COVID-19 treatment guidelines. Available: https://covid19treatmentguidelines.nih.gov/ [Accessed 23 Apr 2020].

Wei Tang, Z. Cao, Mingfeng Han, Zhengyan Wang, Junwen Chen, Wenjin Sun, Yaojie Wu, W. Xiao, Shengyong Liu, E. Chen, Wei Chen, Xiongbiao Wang, Jiuyong Yang, Jun Lin, Qing-xia Zhao, You-qin Yan, Zhibin Xie, Dan-Qi Li, Yaofeng Yang, Leshan Liu, J. Qu, G. Ning, G. Shi, Q. Xie (2020)

Hydroxychloroquine in patients with COVID-19: an open-label, randomized, controlled trial

medRxiv

U. Hamid, A. Krasnodembskaya, M. Fitzgerald, M. Shyamsundar, A. Kissenpfennig, C. Scott, Emma Lefrançais, M. Looney, R. Verghis, J. Scott, A. Simpson, J. McNamee, D. McAuley, D. McAuley, C. O’Kane (2017)

Aspirin reduces lipopolysaccharide-induced pulmonary inflammation in human models of ARDS

Thorax, 72

(Check R. Failure rates during reuse of disposable N95 masks in clinical practice in the emergency department," presented at the American College of Emergency Physicians Research Forum, 2020. Available: https://els-jbs-prod-cdn.jbs.elsevierhealth.com/pb/assets/raw/Health%20Advance/journals/ymem/YMEM764Sfinalv2.pdf)

Check R. Failure rates during reuse of disposable N95 masks in clinical practice in the emergency department," presented at the American College of Emergency Physicians Research Forum, 2020. Available: https://els-jbs-prod-cdn.jbs.elsevierhealth.com/pb/assets/raw/Health%20Advance/journals/ymem/YMEM764Sfinalv2.pdf, Check R. Failure rates during reuse of disposable N95 masks in clinical practice in the emergency department," presented at the American College of Emergency Physicians Research Forum, 2020. Available: https://els-jbs-prod-cdn.jbs.elsevierhealth.com/pb/assets/raw/Health%20Advance/journals/ymem/YMEM764Sfinalv2.pdf

A. Chowdhury, S. Chowdhury, Md Islam, A. Islam, J. Vaughan (1997)

Control of tuberculosis by community health workers in Bangladesh

The Lancet, 350

F. Zhou, Ting Yu, R. Du, Guohui Fan, Y. Liu, Zhibo Liu, J. Xiang, Ye-ming Wang, Bin Song, Xiaoying Gu, Lulu Guan, Yuan Wei, Hui Li, Xudong Wu, Jiuyang Xu, Shengjin Tu, Yi Zhang, Hua Chen, B. Cao (2020)

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Lancet (London, England), 395

(RECOVERY Collaborative Group, Horby P, Lim WS, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 2021;384:693–704. 10.1056/NEJMoa202143632678530)

RECOVERY Collaborative Group, Horby P, Lim WS, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 2021;384:693–704. 10.1056/NEJMoa202143632678530

RECOVERY Collaborative Group, Horby P, Lim WS, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 2021;384:693–704. 10.1056/NEJMoa202143632678530, RECOVERY Collaborative Group, Horby P, Lim WS, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 2021;384:693–704. 10.1056/NEJMoa202143632678530

Horby (2021)

Dexamethasone in hospitalized patients with Covid-19

N Engl J Med, 384

(Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054–62. 10.1016/S0140-6736(20)30566-332171076)

Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054–62. 10.1016/S0140-6736(20)30566-332171076, Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054–62. 10.1016/S0140-6736(20)30566-332171076

(Anon. An EUA for Bamlanivimab-A monoclonal antibody for COVID-19. JAMA 2021;325:880–1. 10.1001/jama.2020.2441533306087)

Anon. An EUA for Bamlanivimab-A monoclonal antibody for COVID-19. JAMA 2021;325:880–1. 10.1001/jama.2020.2441533306087

Anon. An EUA for Bamlanivimab-A monoclonal antibody for COVID-19. JAMA 2021;325:880–1. 10.1001/jama.2020.2441533306087, Anon. An EUA for Bamlanivimab-A monoclonal antibody for COVID-19. JAMA 2021;325:880–1. 10.1001/jama.2020.2441533306087

(Thachil J, Tang N, Gando S, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost 2020;18:1023–6. 10.1111/jth.1481032338827)

Thachil J, Tang N, Gando S, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost 2020;18:1023–6. 10.1111/jth.1481032338827

Thachil J, Tang N, Gando S, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost 2020;18:1023–6. 10.1111/jth.1481032338827, Thachil J, Tang N, Gando S, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost 2020;18:1023–6. 10.1111/jth.1481032338827

(2020)

As men wage bloody battle for Syrian Province, women sew face masks to fight the next threat

Anup Agarwal, A. Mukherjee, G. Kumar, P. Chatterjee, T. Bhatnagar, P. Malhotra (2020)

Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)

The BMJ, 371

Ventura Simonovich, Leandro Pratx, P. Scibona, M. Beruto, M. Vallone, C. Vázquez, N. Savoy, D. Giunta, Lucia Perez, M. Sanchez, A. Gamarnik, D. Ojeda, Diego Santoro, P. Camino, Sebastian Antelo, Karina Rainero, G. Vidiella, E. Miyazaki, W. Cornistein, Omar Trabadelo, F. Ross, M. Spotti, Gabriel Funtowicz, W. Scordo, M. Losso, I. Ferniot, Pablo Pardo, Eulalia Rodríguez, P. Rucci, J. Pasquali, N. Fuentes, M. Esperatti, G. Speroni, E. Nannini, Alejandra Matteaccio, H. Michelangelo, D. Follmann, H. Lane, W. Belloso (2020)

A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia

The New England Journal of Medicine

Statement on IJAA paper

W. Self, M. Semler, Lindsay Leither, J. Casey, D. Angus, R. Brower, Steven Chang, S. Collins, John Eppensteiner, M. Filbin, D. Files, K. Gibbs, A. Ginde, M. Gong, F. Harrell, D. Hayden, C. Hough, N. Johnson, Akram Khan, C. Lindsell, M. Matthay, M. Moss, P. Park, T. Rice, B. Robinson, D. Schoenfeld, N. Shapiro, J. Steingrub, C. Ulysse, A. Weissman, D. Yealy, B. Thompson, Samuel Brown (2020)

Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial.

JAMA

(2020)

COvid pRONe hypoxemiA): Prone positioning for hypoxemic COVID-19 patients with Do-Not-Intubate goals (CORONA) -Identifier NCT04402879

Awake prone positioning to reduce invasive ventilation in COVID-19 induced acute respiratory failurE

(Kratzel A, Todt D, V'kovski P, et al. Inactivation of severe acute respiratory syndrome coronavirus 2 by WHO-Recommended hand rub formulations and alcohols. Emerg Infect Dis 2020;26:1592–5. 10.3201/eid2607.20091532284092)

Kratzel A, Todt D, V'kovski P, et al. Inactivation of severe acute respiratory syndrome coronavirus 2 by WHO-Recommended hand rub formulations and alcohols. Emerg Infect Dis 2020;26:1592–5. 10.3201/eid2607.20091532284092, Kratzel A, Todt D, V'kovski P, et al. Inactivation of severe acute respiratory syndrome coronavirus 2 by WHO-Recommended hand rub formulations and alcohols. Emerg Infect Dis 2020;26:1592–5. 10.3201/eid2607.20091532284092

(Caputo ND, Strayer RJ, Levitan R. Early Self-Proning in awake, Non-intubated patients in the emergency department: a single ED's experience during the COVID-19 pandemic. Acad Emerg Med 2020;27:375–8. 10.1111/acem.1399432320506)

Caputo ND, Strayer RJ, Levitan R. Early Self-Proning in awake, Non-intubated patients in the emergency department: a single ED's experience during the COVID-19 pandemic. Acad Emerg Med 2020;27:375–8. 10.1111/acem.1399432320506, Caputo ND, Strayer RJ, Levitan R. Early Self-Proning in awake, Non-intubated patients in the emergency department: a single ED's experience during the COVID-19 pandemic. Acad Emerg Med 2020;27:375–8. 10.1111/acem.1399432320506

M. Tobin (2020)

Basing Respiratory Management of COVID-19 on Physiological Principles

American Journal of Respiratory and Critical Care Medicine, 201

(Borba MGSet al. Chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (SARS-CoV-2) infection: preliminary safety results of a randomized, double-blinded, phase IIb clinical trial (CloroCovid-19 study). medRxiv 2020:2020.04.07.20056424.)

Borba MGSet al. Chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (SARS-CoV-2) infection: preliminary safety results of a randomized, double-blinded, phase IIb clinical trial (CloroCovid-19 study). medRxiv 2020:2020.04.07.20056424., Borba MGSet al. Chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (SARS-CoV-2) infection: preliminary safety results of a randomized, double-blinded, phase IIb clinical trial (CloroCovid-19 study). medRxiv 2020:2020.04.07.20056424.

(Hung IF-N, Lung K-C, Tso EY-K, et al. Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet 2020;395:1695–704. 10.1016/S0140-6736(20)31042-432401715)

Hung IF-N, Lung K-C, Tso EY-K, et al. Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet 2020;395:1695–704. 10.1016/S0140-6736(20)31042-432401715, Hung IF-N, Lung K-C, Tso EY-K, et al. Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet 2020;395:1695–704. 10.1016/S0140-6736(20)31042-432401715

(Miller NP, Milsom P, Johnson G, et al. Community health workers during the Ebola outbreak in guinea, Liberia, and Sierra Leone. J Glob Health 2018;8:020601. 10.7189/jogh-08-02060130023054)

Miller NP, Milsom P, Johnson G, et al. Community health workers during the Ebola outbreak in guinea, Liberia, and Sierra Leone. J Glob Health 2018;8:020601. 10.7189/jogh-08-02060130023054

Miller NP, Milsom P, Johnson G, et al. Community health workers during the Ebola outbreak in guinea, Liberia, and Sierra Leone. J Glob Health 2018;8:020601. 10.7189/jogh-08-02060130023054, Miller NP, Milsom P, Johnson G, et al. Community health workers during the Ebola outbreak in guinea, Liberia, and Sierra Leone. J Glob Health 2018;8:020601. 10.7189/jogh-08-02060130023054

(Magagnoli J, Narendran S, Pereira F, et al. Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19. medRxiv 2020. 10.1101/2020.04.16.20065920. [Epub ahead of print: 21 Apr 2020].)

Magagnoli J, Narendran S, Pereira F, et al. Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19. medRxiv 2020. 10.1101/2020.04.16.20065920. [Epub ahead of print: 21 Apr 2020]., Magagnoli J, Narendran S, Pereira F, et al. Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19. medRxiv 2020. 10.1101/2020.04.16.20065920. [Epub ahead of print: 21 Apr 2020].

(Ehiri JE, Gunn JKL, Center KE, et al. Training and deployment of lay refugee/internally displaced persons to provide basic health services in camps: a systematic review. Glob Health Action 2014;7:23902. 10.3402/gha.v7.2390225280734)

Ehiri JE, Gunn JKL, Center KE, et al. Training and deployment of lay refugee/internally displaced persons to provide basic health services in camps: a systematic review. Glob Health Action 2014;7:23902. 10.3402/gha.v7.2390225280734, Ehiri JE, Gunn JKL, Center KE, et al. Training and deployment of lay refugee/internally displaced persons to provide basic health services in camps: a systematic review. Glob Health Action 2014;7:23902. 10.3402/gha.v7.2390225280734

(Kumar A, Kasloff SB, Leung A, et al. Decontamination of N95 masks for re-use employing 7 widely available sterilization methods. PLoS One 2020;15:e0243965. 10.1371/journal.pone.024396533326504)

Kumar A, Kasloff SB, Leung A, et al. Decontamination of N95 masks for re-use employing 7 widely available sterilization methods. PLoS One 2020;15:e0243965. 10.1371/journal.pone.024396533326504

Kumar A, Kasloff SB, Leung A, et al. Decontamination of N95 masks for re-use employing 7 widely available sterilization methods. PLoS One 2020;15:e0243965. 10.1371/journal.pone.024396533326504, Kumar A, Kasloff SB, Leung A, et al. Decontamination of N95 masks for re-use employing 7 widely available sterilization methods. PLoS One 2020;15:e0243965. 10.1371/journal.pone.024396533326504

(CORONA (COvid pRONe hypoxemiA): Prone positioning for hypoxemic COVID-19 patients with Do-Not-Intubate goals (CORONA) - Identifier NCT04402879," ed: ClinicalTrials.gov, 2020.)

CORONA (COvid pRONe hypoxemiA): Prone positioning for hypoxemic COVID-19 patients with Do-Not-Intubate goals (CORONA) - Identifier NCT04402879," ed: ClinicalTrials.gov, 2020.

CORONA (COvid pRONe hypoxemiA): Prone positioning for hypoxemic COVID-19 patients with Do-Not-Intubate goals (CORONA) - Identifier NCT04402879," ed: ClinicalTrials.gov, 2020., CORONA (COvid pRONe hypoxemiA): Prone positioning for hypoxemic COVID-19 patients with Do-Not-Intubate goals (CORONA) - Identifier NCT04402879," ed: ClinicalTrials.gov, 2020.

S. Kemp, D. Collier, R. Datir, I. Ferreira, S. Gayed, A. Jahun, M. Hosmillo, C. Rees-Spear, P. Mlcochova, Ines Lumb, D. Roberts, Anita Chandra, Nigel Temperton, K. Sharrocks, E. Blane, J. Briggs, M. Gils, K. Smith, J. Bradley, C. Smith, R. Doffinger, L. Ceron-Gutierrez, G. Barcenas-Morales, D. Pollock, R. Goldstein, A. Smielewska, J. Skittrall, T. Gouliouris, I. Goodfellow, E. Gkrania-Klotsas, C. Illingworth, L. McCoy, R. Gupta (2020)

Neutralising antibodies in Spike mediated SARS-CoV-2 adaptation

medRxiv

(Alhazzani W, Møller MH, Arabi YM, et al. Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Intensive Care Med 2020;46:854–87. 10.1007/s00134-020-06022-532222812)

Alhazzani W, Møller MH, Arabi YM, et al. Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Intensive Care Med 2020;46:854–87. 10.1007/s00134-020-06022-532222812, Alhazzani W, Møller MH, Arabi YM, et al. Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Intensive Care Med 2020;46:854–87. 10.1007/s00134-020-06022-532222812

(Goyal P, Choi JJ, Pinheiro LC, et al. Clinical characteristics of Covid-19 in New York City. N Engl J Med 2020;382:2372–4. 10.1056/NEJMc201041932302078)

Goyal P, Choi JJ, Pinheiro LC, et al. Clinical characteristics of Covid-19 in New York City. N Engl J Med 2020;382:2372–4. 10.1056/NEJMc201041932302078

Goyal P, Choi JJ, Pinheiro LC, et al. Clinical characteristics of Covid-19 in New York City. N Engl J Med 2020;382:2372–4. 10.1056/NEJMc201041932302078, Goyal P, Choi JJ, Pinheiro LC, et al. Clinical characteristics of Covid-19 in New York City. N Engl J Med 2020;382:2372–4. 10.1056/NEJMc201041932302078

COVID-19: data

(Self WH, Semler MW, Leither LM, et al. Effect of hydroxychloroquine on clinical status at 14 days in hospitalized patients with COVID-19: a randomized clinical trial. JAMA 2020;324:2165–76. 10.1001/jama.2020.2224033165621)

Self WH, Semler MW, Leither LM, et al. Effect of hydroxychloroquine on clinical status at 14 days in hospitalized patients with COVID-19: a randomized clinical trial. JAMA 2020;324:2165–76. 10.1001/jama.2020.2224033165621, Self WH, Semler MW, Leither LM, et al. Effect of hydroxychloroquine on clinical status at 14 days in hospitalized patients with COVID-19: a randomized clinical trial. JAMA 2020;324:2165–76. 10.1001/jama.2020.2224033165621

(McGinley L. Only one COVID-19 treatment is designed to keep people out of the hospital. Many overburdened hospitals are not offering it. The Washington Post, 2020.)

McGinley L. Only one COVID-19 treatment is designed to keep people out of the hospital. Many overburdened hospitals are not offering it. The Washington Post, 2020.

McGinley L. Only one COVID-19 treatment is designed to keep people out of the hospital. Many overburdened hospitals are not offering it. The Washington Post, 2020., McGinley L. Only one COVID-19 treatment is designed to keep people out of the hospital. Many overburdened hospitals are not offering it. The Washington Post, 2020.

(UNHCR. Lebanon crisis response plan, 2019. Available: https://data2.unhcr.org/en/documents/download/68651)

UNHCR. Lebanon crisis response plan, 2019. Available: https://data2.unhcr.org/en/documents/download/68651

UNHCR. Lebanon crisis response plan, 2019. Available: https://data2.unhcr.org/en/documents/download/68651, UNHCR. Lebanon crisis response plan, 2019. Available: https://data2.unhcr.org/en/documents/download/68651

S. Omer, P. Malani, C. Rio (2020)

The COVID-19 Pandemic in the US: A Clinical Update.

JAMA

Manli Wang, Ruiyuan Cao, Lei-ke Zhang, Xinglou Yang, Jia Liu, Mingyue Xu, Z. Shí, Zhìhóng Hú, Wu Zhong, Gengfu Xiao (2020)

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

Cell Research, 30

N. Popa-Fotea (2021)

Dexamethasone in Hospitalized Patients with Covid-19

Romanian Archives of Microbiology and Immunology, 80

(Boseley S. Nine out of 10 in poor nations to miss out on inoculation as West buys up Covid vaccines. The Guardian, 2020.)

Boseley S. Nine out of 10 in poor nations to miss out on inoculation as West buys up Covid vaccines. The Guardian, 2020.

Boseley S. Nine out of 10 in poor nations to miss out on inoculation as West buys up Covid vaccines. The Guardian, 2020., Boseley S. Nine out of 10 in poor nations to miss out on inoculation as West buys up Covid vaccines. The Guardian, 2020.

(2020)

Keeping the coronavirus from infecting healthcare workers. The New Yorker

(Ruan Q, Yang K, Wang W, et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 2020;46:846–8. 10.1007/s00134-020-05991-x32125452)

Ruan Q, Yang K, Wang W, et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 2020;46:846–8. 10.1007/s00134-020-05991-x32125452, Ruan Q, Yang K, Wang W, et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 2020;46:846–8. 10.1007/s00134-020-05991-x32125452

Anonymous (2020)

An EUA for bamlanivimab - a monoclonal antibody for COVID-19.

The Medical letter on drugs and therapeutics, 62 1612

(MacIntyre CR, Seale H, Dung TC, et al. A cluster randomised trial of cloth masks compared with medical masks in healthcare workers. BMJ Open 2015;5:e006577. 10.1136/bmjopen-2014-006577)

MacIntyre CR, Seale H, Dung TC, et al. A cluster randomised trial of cloth masks compared with medical masks in healthcare workers. BMJ Open 2015;5:e006577. 10.1136/bmjopen-2014-006577

MacIntyre CR, Seale H, Dung TC, et al. A cluster randomised trial of cloth masks compared with medical masks in healthcare workers. BMJ Open 2015;5:e006577. 10.1136/bmjopen-2014-006577, MacIntyre CR, Seale H, Dung TC, et al. A cluster randomised trial of cloth masks compared with medical masks in healthcare workers. BMJ Open 2015;5:e006577. 10.1136/bmjopen-2014-006577

(Doshi S, Banavar SP, Flaum E, et al. Applying heat and humidity using stove boiled water for decontamination of N95 respirators in low resource settings. medRxiv 2020.)

Doshi S, Banavar SP, Flaum E, et al. Applying heat and humidity using stove boiled water for decontamination of N95 respirators in low resource settings. medRxiv 2020.

Doshi S, Banavar SP, Flaum E, et al. Applying heat and humidity using stove boiled water for decontamination of N95 respirators in low resource settings. medRxiv 2020., Doshi S, Banavar SP, Flaum E, et al. Applying heat and humidity using stove boiled water for decontamination of N95 respirators in low resource settings. medRxiv 2020.

Nancy Leung, D. Chu, E. Shiu, Kwok-Hung Chan, J. Mcdevitt, Benien Hau, H. Yen, Yuguo Li, D. Ip, J. Peiris, W. Seto, G. Leung, D. Milton, B. Cowling (2020)

Respiratory virus shedding in exhaled breath and efficacy of face masks

Nature Medicine, 26

(2020)

Doctors come under attack in India as coronavirus stigma grows

(Davidson BL, Verheijen S, Lensing AWA, et al. Bleeding risk of patients with acute venous thromboembolism taking nonsteroidal anti-inflammatory drugs or aspirin. JAMA Intern Med 2014;174:947–53. 10.1001/jamainternmed.2014.94624733305)

Davidson BL, Verheijen S, Lensing AWA, et al. Bleeding risk of patients with acute venous thromboembolism taking nonsteroidal anti-inflammatory drugs or aspirin. JAMA Intern Med 2014;174:947–53. 10.1001/jamainternmed.2014.94624733305, Davidson BL, Verheijen S, Lensing AWA, et al. Bleeding risk of patients with acute venous thromboembolism taking nonsteroidal anti-inflammatory drugs or aspirin. JAMA Intern Med 2014;174:947–53. 10.1001/jamainternmed.2014.94624733305

N. Tang, Huan Bai, Xing Chen, Jiale Gong, Dengju Li, Ziyong Sun (2020)

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

Journal of Thrombosis and Haemostasis, 18

Grace Mwai, G. Mburu, K. Torpey, P. Frost, N. Ford, J. Seeley (2013)

Role and outcomes of community health workers in HIV care in sub-Saharan Africa: a systematic review

Journal of the International AIDS Society, 16

United Nations High Commissioner for Refugees. Response to Coronavirus -COVID-19

(Centers for Disease Control and Prevention. COVID-19 in racial and ethnic minority groups. Available: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/racial-ethnic-minorities.html [Accessed 28 Apr 2020].)

Centers for Disease Control and Prevention. COVID-19 in racial and ethnic minority groups. Available: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/racial-ethnic-minorities.html [Accessed 28 Apr 2020]., Centers for Disease Control and Prevention. COVID-19 in racial and ethnic minority groups. Available: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/racial-ethnic-minorities.html [Accessed 28 Apr 2020].

N. Miller, P. Milsom, Ginger Johnson, J. Bedford, Aline Kapeu, A. Diallo, Kebir Hassen, Nuzhat Rafique, K. Islam, R. Camara, J. Kandeh, C. Wesseh, K. Rasanathan, Jérôme Zambruni, H. Papowitz (2018)

Community health workers during the Ebola outbreak in Guinea, Liberia, and Sierra Leone

Journal of Global Health, 8

(Bilaloglu S, Aphinyanaphongs Y, Jones S, et al. Thrombosis in hospitalized patients with COVID-19 in a New York City health system. JAMA 2020;324:799–801. 10.1001/jama.2020.1337232702090)

Bilaloglu S, Aphinyanaphongs Y, Jones S, et al. Thrombosis in hospitalized patients with COVID-19 in a New York City health system. JAMA 2020;324:799–801. 10.1001/jama.2020.1337232702090

Bilaloglu S, Aphinyanaphongs Y, Jones S, et al. Thrombosis in hospitalized patients with COVID-19 in a New York City health system. JAMA 2020;324:799–801. 10.1001/jama.2020.1337232702090, Bilaloglu S, Aphinyanaphongs Y, Jones S, et al. Thrombosis in hospitalized patients with COVID-19 in a New York City health system. JAMA 2020;324:799–801. 10.1001/jama.2020.1337232702090

R. MacIntyre, H. Seale, T. Dung, N. Hien, P. Nga, A. Chughtai, B. Rahman, D. Dwyer, Quanyi Wang (2015)

A cluster randomised trial of cloth masks compared with medical masks in healthcare workers

BMJ Open, 5

J. Chow, A. Khanna, S. Kethireddy, D. Yamane, A. Levine, Amanda Jackson, M. McCurdy, A. Tabatabai, G. Kumar, P. Park, I. Benjenk, J. Menaker, Nayab Ahmed, Evan Glidewell, Elizabeth Presutto, Shannon Cain, Naeha Haridasa, Wesley Field, Jacob Fowler, D. Trinh, Kathleen Johnson, Amanjyot Kaur, A. Lee, Kyle Sebastian, Allison Ulrich, S. Peña, R. Carpenter, S. Sudhakar, Pushpinder Uppal, Benjamin Fedeles, Aaron Sachs, Layth Dahbour, W. Teeter, Kenichi Tanaka, S. Galvagno, D. Herr, T. Scalea, M. Mazzeffi (2020)

Aspirin Use Is Associated With Decreased Mechanical Ventilation, Intensive Care Unit Admission, and In-Hospital Mortality in Hospitalized Patients With Coronavirus Disease 2019

Anesthesia & Analgesia, 132

P. Mehta, D. McAuley, Michael Brown, Emilie Sanchez, R. Tattersall, J. Manson (2020)

COVID-19: consider cytokine storm syndromes and immunosuppression

Lancet (London, England), 395

(Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020;395:1033–4. 10.1016/S0140-6736(20)30628-032192578)

Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020;395:1033–4. 10.1016/S0140-6736(20)30628-032192578

Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020;395:1033–4. 10.1016/S0140-6736(20)30628-032192578, Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020;395:1033–4. 10.1016/S0140-6736(20)30628-032192578

Chen Wang, P. Horby, F. Hayden, George Gao (2020)

Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury

Lancet (London, England), 395

(I. J. o. A. Agents. Statement on IJAA paper. Available: https://www.isac.world/news-and-publications/official-isac-statement [Accessed 17 Apr 2020].)

I. J. o. A. Agents. Statement on IJAA paper. Available: https://www.isac.world/news-and-publications/official-isac-statement [Accessed 17 Apr 2020].

I. J. o. A. Agents. Statement on IJAA paper. Available: https://www.isac.world/news-and-publications/official-isac-statement [Accessed 17 Apr 2020]., I. J. o. A. Agents. Statement on IJAA paper. Available: https://www.isac.world/news-and-publications/official-isac-statement [Accessed 17 Apr 2020].

Response to Coronavirus - COVID-19

(Day M. Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists. BMJ 2020;368:m1086. 10.1136/bmj.m108632184201)

Day M. Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists. BMJ 2020;368:m1086. 10.1136/bmj.m108632184201

Day M. Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists. BMJ 2020;368:m1086. 10.1136/bmj.m108632184201, Day M. Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists. BMJ 2020;368:m1086. 10.1136/bmj.m108632184201

Siddharth Doshi, Samhita Banavar, Eliott Flaum, S. Kulkarni, Ulhas Vaidya, Shailabh Kumar, Tyler Chen, A. Bhattacharya, M. Prakash (2020)

Applying heat and humidity using stove boiled water for decontamination of N95 respirators in low resource settings

PLoS ONE, 16

J. Beigel, K. Tomashek, L. Dodd, A. Mehta, B. Zingman, A. Kalil, E. Hohmann, H. Chu, A. Luetkemeyer, S. Kline, D. Castilla, R. Finberg, K. Dierberg, V. Tapson, L. Hsieh, T. Patterson, R. Paredes, D. Sweeney, W. Short, G. Touloumi, D. Lye, N. Ohmagari, M. Oh, G. Ruiz-Palacios, T. Benfield, G. Fätkenheuer, M. Kortepeter, R. Atmar, C. Creech, J. Lundgren, A. Babiker, S. Pett, J. Neaton, T. Burgess, Tyler Bonnett, Michelle Green, M. Makowski, A. Osinusi, S. Nayak, H. Lane (2020)

Remdesivir for the Treatment of Covid-19 — Final Report

The New England Journal of Medicine

(NYC DOH. COVID-19: data. Available: https://www1.nyc.gov/site/doh/covid/covid-19-data.page [Accessed 03 May 2020].)

NYC DOH. COVID-19: data. Available: https://www1.nyc.gov/site/doh/covid/covid-19-data.page [Accessed 03 May 2020].

NYC DOH. COVID-19: data. Available: https://www1.nyc.gov/site/doh/covid/covid-19-data.page [Accessed 03 May 2020]., NYC DOH. COVID-19: data. Available: https://www1.nyc.gov/site/doh/covid/covid-19-data.page [Accessed 03 May 2020].

(Agarwal A, Mukherjee A, Kumar G. Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID trial). BMJ 2020;151:m3939. 10.1136/bmj.m3939)

Agarwal A, Mukherjee A, Kumar G. Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID trial). BMJ 2020;151:m3939. 10.1136/bmj.m3939, Agarwal A, Mukherjee A, Kumar G. Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID trial). BMJ 2020;151:m3939. 10.1136/bmj.m3939

S. Bilaloglu, Y. Aphinyanaphongs, Simon Jones, E. Iturrate, J. Hochman, J. Berger (2020)

Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System.

JAMA

(Dadouch S. As men wage bloody battle for Syrian Province, women sew face masks to fight the next threat. Washington Post, 2020.)

Dadouch S. As men wage bloody battle for Syrian Province, women sew face masks to fight the next threat. Washington Post, 2020.

Dadouch S. As men wage bloody battle for Syrian Province, women sew face masks to fight the next threat. Washington Post, 2020., Dadouch S. As men wage bloody battle for Syrian Province, women sew face masks to fight the next threat. Washington Post, 2020.

Chao-min Wu, Xiaoyan Chen, Y. Cai, Jia’an Xia, Xiaoping Zhou, Shan Xu, Hanping Huang, Li Zhang, Xia Zhou, C. Du, Yuye Zhang, Juan Song, Sijiao Wang, Yencheng Chao, Zeyong Yang, Jie Xu, Xin Zhou, Dechang Chen, W. Xiong, Lei Xu, F. Zhou, Jinjun Jiang, C. Bai, Junhua Zheng, Yuanlin Song (2020)

Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China

The Journal of Emergency Medicine, 58

10.1101/2020.05.28.20113209

Anand Kumar, S. Kasloff, Anders Leung, T. Cutts, J. Strong, K. Hills, F. Gu, Paul Chen, G. Vazquez-Grande, Barret Rush, S. Lother, Kimberly Malo, R. Zarychanski, J. Krishnan (2020)

Decontamination of N95 masks for re-use employing 7 widely available sterilization methods

PLoS ONE, 15

(Gudbjartsson DF, Helgason A, Jonsson H, et al. Spread of SARS-CoV-2 in the Icelandic population. N Engl J Med 2020;382:2302–15. 10.1056/NEJMoa200610032289214)

Gudbjartsson DF, Helgason A, Jonsson H, et al. Spread of SARS-CoV-2 in the Icelandic population. N Engl J Med 2020;382:2302–15. 10.1056/NEJMoa200610032289214

Gudbjartsson DF, Helgason A, Jonsson H, et al. Spread of SARS-CoV-2 in the Icelandic population. N Engl J Med 2020;382:2302–15. 10.1056/NEJMoa200610032289214, Gudbjartsson DF, Helgason A, Jonsson H, et al. Spread of SARS-CoV-2 in the Icelandic population. N Engl J Med 2020;382:2302–15. 10.1056/NEJMoa200610032289214

(Sjoding MW, Dickson RP, Iwashyna TJ, et al. Racial bias in pulse oximetry measurement. N Engl J Med 2020;383:2477–8. 10.1056/NEJMc202924033326721)

Sjoding MW, Dickson RP, Iwashyna TJ, et al. Racial bias in pulse oximetry measurement. N Engl J Med 2020;383:2477–8. 10.1056/NEJMc202924033326721

Sjoding MW, Dickson RP, Iwashyna TJ, et al. Racial bias in pulse oximetry measurement. N Engl J Med 2020;383:2477–8. 10.1056/NEJMc202924033326721, Sjoding MW, Dickson RP, Iwashyna TJ, et al. Racial bias in pulse oximetry measurement. N Engl J Med 2020;383:2477–8. 10.1056/NEJMc202924033326721

W. Alhazzani, M. Møller, Y. Arabi, M. Loeb, M. Gong, E. Fan, S. Oczkowski, M. Levy, L. Derde, A. Dzierba, B. Du, M. Aboodi, H. Wunsch, M. Cecconi, Y. Koh, D. Chertow, K. Maitland, F. Alshamsi, E. Belley‐Cote, M. Greco, M. Laundy, Jill Morgan, J. Kesecioglu, A. McGeer, L. Mermel, M. Mammen, P. Alexander, A. Arrington, J. Centofanti, G. Citerio, B. Baw, Z. Memish, N. Hammond, F. Hayden, Laura Evans, A. Rhodes (2020)

Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)

Intensive Care Medicine, 46

J. Ehiri, J. Gunn, K. Center, Ying Li, M. Rouhani, E. Ezeanolue (2014)

Training and deployment of lay refugee/internally displaced persons to provide basic health services in camps: a systematic review

Global Health Action, 7

J. Thachil, N. Tang, S. Gando, A. Falanga, M. Cattaneo, M. Levi, Cary Clark, T. Iba (2020)

ISTH interim guidance on recognition and management of coagulopathy in COVID‐19

Journal of Thrombosis and Haemostasis, 18

B. Davidson, S. Verheijen, A. Lensing, M. Gebel, T. Brighton, R. Lyons, Jeffrey Rehm, M. Prins (2014)

Bleeding risk of patients with acute venous thromboembolism taking nonsteroidal anti-inflammatory drugs or aspirin.

JAMA internal medicine, 174 6

Qiurong Ruan, Kun Yang, Wenxia Wang, Lingyu Jiang, Jianxin Song (2020)

Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China

Intensive Care Medicine, 46

(United Nations High Commissioner for Refugees. Response to Coronavirus - COVID-19. Available: https://www.unhcr.org/lb/corona [Accessed 24 Apr 2020].)

United Nations High Commissioner for Refugees. Response to Coronavirus - COVID-19. Available: https://www.unhcr.org/lb/corona [Accessed 24 Apr 2020].

United Nations High Commissioner for Refugees. Response to Coronavirus - COVID-19. Available: https://www.unhcr.org/lb/corona [Accessed 24 Apr 2020]., United Nations High Commissioner for Refugees. Response to Coronavirus - COVID-19. Available: https://www.unhcr.org/lb/corona [Accessed 24 Apr 2020].

(Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020;180:934–43. 10.1001/jamainternmed.2020.099432167524)

Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020;180:934–43. 10.1001/jamainternmed.2020.099432167524, Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020;180:934–43. 10.1001/jamainternmed.2020.099432167524

(Simonovich VA, Burgos Pratx LD, Scibona P, et al. A randomized trial of convalescent plasma in Covid-19 severe pneumonia. N Engl J Med 2021;384:619–29. 10.1056/NEJMoa203130433232588)

Simonovich VA, Burgos Pratx LD, Scibona P, et al. A randomized trial of convalescent plasma in Covid-19 severe pneumonia. N Engl J Med 2021;384:619–29. 10.1056/NEJMoa203130433232588

Simonovich VA, Burgos Pratx LD, Scibona P, et al. A randomized trial of convalescent plasma in Covid-19 severe pneumonia. N Engl J Med 2021;384:619–29. 10.1056/NEJMoa203130433232588, Simonovich VA, Burgos Pratx LD, Scibona P, et al. A randomized trial of convalescent plasma in Covid-19 severe pneumonia. N Engl J Med 2021;384:619–29. 10.1056/NEJMoa203130433232588

D. Gudbjartsson, A. Helgason, Hákon Jónsson, O. Magnusson, Páll Melsted, G. Norddahl, Jona Saemundsdottir, A. Sigurdsson, P. Sulem, A. Agustsdottir, Berglind Eiríksdottir, Run Fridriksdottir, Elisabet Gardarsdottir, G. Georgsson, Ó. Grétarsdóttir, Kjartan Gudmundsson, T. Gunnarsdottir, Arnaldur Gylfason, H. Hólm, B. Jensson, Á. Jónasdóttir, F. Jonsson, K. Josefsdottir, T. Kristjánsson, Droplaug Magnúsdóttir, L. Roux, G. Sigmundsdóttir, Gardar Sveinbjornsson, Kristin Sveinsdottir, M. Sveinsdóttir, Emil Thorarensen, Bjarni Thorbjornsson, A. Löve, G. Másson, I. Jónsdóttir, A. Möller, T. Gudnason, K. Kristinsson, U. Thorsteinsdóttir, K. Stefánsson (2020)

Spread of SARS-CoV-2 in the Icelandic Population

The New England Journal of Medicine

COVID-19 treatment guidelines

N. Jagan, L. Morrow, R. Walters, Lauren Klein, T. Wallen, J. Chung, R. Plambeck (2020)

The POSITIONED Study: Prone Positioning in Nonventilated Coronavirus Disease 2019 Patients—A Retrospective Analysis

Critical Care Explorations, 2

Eric Scholten, J. Beitler, G. Prisk, A. Malhotra (2017)

Treatment of ARDS With Prone Positioning.

Chest, 151 1

(Bouak F, Eaton D. Oxygen therapy. DRDC Toronto TM 2004;112.)

Bouak F, Eaton D. Oxygen therapy. DRDC Toronto TM 2004;112.

Bouak F, Eaton D. Oxygen therapy. DRDC Toronto TM 2004;112., Bouak F, Eaton D. Oxygen therapy. DRDC Toronto TM 2004;112.

(Hamid U, Krasnodembskaya A, Fitzgerald M, et al. Aspirin reduces lipopolysaccharide-induced pulmonary inflammation in human models of ARDS. Thorax 2017;72:971–80. 10.1136/thoraxjnl-2016-20857128082531)

Hamid U, Krasnodembskaya A, Fitzgerald M, et al. Aspirin reduces lipopolysaccharide-induced pulmonary inflammation in human models of ARDS. Thorax 2017;72:971–80. 10.1136/thoraxjnl-2016-20857128082531, Hamid U, Krasnodembskaya A, Fitzgerald M, et al. Aspirin reduces lipopolysaccharide-induced pulmonary inflammation in human models of ARDS. Thorax 2017;72:971–80. 10.1136/thoraxjnl-2016-20857128082531

A. Kratzel, D. Todt, P. V’kovski, Silvio Steiner, Mitra Gultom, T. Thao, N. Ebert, M. Holwerda, J. Steinmann, Daniela Niemeyer, R. Dijkman, G. Kampf, C. Drosten, E. Steinmann, V. Thiel, S. Pfaender (2020)

Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 by WHO-Recommended Hand Rub Formulations and Alcohols

Emerging Infectious Diseases, 26

(Padrão EMH, Valente FS, Besen BAMP, et al. Awake prone positioning in COVID-19 hypoxemic respiratory failure: exploratory findings in a single-center retrospective cohort study. Acad Emerg Med 2020;27:1249–59. 10.1111/acem.1416033107664)

Padrão EMH, Valente FS, Besen BAMP, et al. Awake prone positioning in COVID-19 hypoxemic respiratory failure: exploratory findings in a single-center retrospective cohort study. Acad Emerg Med 2020;27:1249–59. 10.1111/acem.1416033107664, Padrão EMH, Valente FS, Besen BAMP, et al. Awake prone positioning in COVID-19 hypoxemic respiratory failure: exploratory findings in a single-center retrospective cohort study. Acad Emerg Med 2020;27:1249–59. 10.1111/acem.1416033107664

E. Ruzicka, H. Musgrave (1950)

Oxygen therapy.

The Surgical clinics of North America, 30 3

(Yao X, Ye F, Zhang M, et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis 2020;71:732–9. 10.1093/cid/ciaa23732150618)

Yao X, Ye F, Zhang M, et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis 2020;71:732–9. 10.1093/cid/ciaa23732150618, Yao X, Ye F, Zhang M, et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis 2020;71:732–9. 10.1093/cid/ciaa23732150618

R. Check, Brian Kelly, K. McMahon, V. Balakrishnan, L. Rivard, Johnathan Pester, D. Jeanmonod, R. Jeanmonod (2021)

Failure Rates During Reuse of Disposable N95 Masks in Clinical Practice in the Emergency Department

Western Journal of Emergency Medicine, 22

(2020)

Only one COVID-19 treatment is designed to keep people out of the hospital. Many overburdened hospitals are not offering it

(Wang M, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 2020;30:269–71. 10.1038/s41422-020-0282-032020029)

Wang M, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 2020;30:269–71. 10.1038/s41422-020-0282-032020029

Wang M, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 2020;30:269–71. 10.1038/s41422-020-0282-032020029, Wang M, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 2020;30:269–71. 10.1038/s41422-020-0282-032020029

(Kemp SA, Collier DA, Datir R, et al. Neutralising antibodies in spike mediated SARS-CoV-2 adaptation. medRxiv 2020. 10.1101/2020.12.05.20241927. [Epub ahead of print: 29 Dec 2020].)

Kemp SA, Collier DA, Datir R, et al. Neutralising antibodies in spike mediated SARS-CoV-2 adaptation. medRxiv 2020. 10.1101/2020.12.05.20241927. [Epub ahead of print: 29 Dec 2020].

Kemp SA, Collier DA, Datir R, et al. Neutralising antibodies in spike mediated SARS-CoV-2 adaptation. medRxiv 2020. 10.1101/2020.12.05.20241927. [Epub ahead of print: 29 Dec 2020]., Kemp SA, Collier DA, Datir R, et al. Neutralising antibodies in spike mediated SARS-CoV-2 adaptation. medRxiv 2020. 10.1101/2020.12.05.20241927. [Epub ahead of print: 29 Dec 2020].

(Alstedter A, Shrivastava B, Pandya D. Doctors come under attack in India as coronavirus stigma grows. Bloomberg News, 2020.)

Alstedter A, Shrivastava B, Pandya D. Doctors come under attack in India as coronavirus stigma grows. Bloomberg News, 2020.

Alstedter A, Shrivastava B, Pandya D. Doctors come under attack in India as coronavirus stigma grows. Bloomberg News, 2020., Alstedter A, Shrivastava B, Pandya D. Doctors come under attack in India as coronavirus stigma grows. Bloomberg News, 2020.

(Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the Treatment of Covid-19 - Final Report. N Engl J Med 2020;383:1813–26. 10.1056/NEJMoa200776432445440)

Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the Treatment of Covid-19 - Final Report. N Engl J Med 2020;383:1813–26. 10.1056/NEJMoa200776432445440

Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the Treatment of Covid-19 - Final Report. N Engl J Med 2020;383:1813–26. 10.1056/NEJMoa200776432445440, Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the Treatment of Covid-19 - Final Report. N Engl J Med 2020;383:1813–26. 10.1056/NEJMoa200776432445440

(Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet 2020;395:473–5. 10.1016/S0140-6736(20)30317-232043983)

Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet 2020;395:473–5. 10.1016/S0140-6736(20)30317-232043983

Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet 2020;395:473–5. 10.1016/S0140-6736(20)30317-232043983, Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet 2020;395:473–5. 10.1016/S0140-6736(20)30317-232043983

(Awake prone positioning to reduce invasive ventilation in COVID-19 induced acute respiratory failurE. Available: https://ClinicalTrials.gov/show/NCT04347941 [Accessed 26 Apr 2020].)

Awake prone positioning to reduce invasive ventilation in COVID-19 induced acute respiratory failurE. Available: https://ClinicalTrials.gov/show/NCT04347941 [Accessed 26 Apr 2020].

Awake prone positioning to reduce invasive ventilation in COVID-19 induced acute respiratory failurE. Available: https://ClinicalTrials.gov/show/NCT04347941 [Accessed 26 Apr 2020]., Awake prone positioning to reduce invasive ventilation in COVID-19 induced acute respiratory failurE. Available: https://ClinicalTrials.gov/show/NCT04347941 [Accessed 26 Apr 2020].

(Tang N, Bai H, Chen X, et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost 2020;18:1094–9. 10.1111/jth.1481732220112)

Tang N, Bai H, Chen X, et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost 2020;18:1094–9. 10.1111/jth.1481732220112, Tang N, Bai H, Chen X, et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost 2020;18:1094–9. 10.1111/jth.1481732220112

I. Hung, K. Lung, E. Tso, R. Liu, T. Chung, M. Chu, Y. Ng, J. Lo, J. Chan, A. Tam, H. Shum, V. Chan, A. Wu, K. Sin, W. Leung, W. Law, D. Lung, Si-Ok Sin, Pauline Yeung, C. Yip, R. Zhang, Agnes Fung, Erica Yan, Kit-Hang Leung, J. Ip, A. Chu, W. Chan, A. Ng, R. Lee, K. Fung, A. Yeung, Tak-chiu Wu, J. Chan, W. Yan, W. Chan, J. Chan, A. Lie, O. Tsang, V. Cheng, T. Que, C. Lau, Kwok-Hung Chan, K. To, K. Yuen (2020)

Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial

Lancet (London, England), 395

(Chowdhury AM, Chowdhury S, Islam MN, et al. Control of tuberculosis by community health workers in Bangladesh. Lancet 1997;350:169–72. 10.1016/S0140-6736(96)11311-89250184)

Chowdhury AM, Chowdhury S, Islam MN, et al. Control of tuberculosis by community health workers in Bangladesh. Lancet 1997;350:169–72. 10.1016/S0140-6736(96)11311-89250184

Chowdhury AM, Chowdhury S, Islam MN, et al. Control of tuberculosis by community health workers in Bangladesh. Lancet 1997;350:169–72. 10.1016/S0140-6736(96)11311-89250184, Chowdhury AM, Chowdhury S, Islam MN, et al. Control of tuberculosis by community health workers in Bangladesh. Lancet 1997;350:169–72. 10.1016/S0140-6736(96)11311-89250184

J. Magagnoli, S. Narendran, Felipe Pereira, T. Cummings, J. Hardin, S. Sutton, J. Ambati (2020)

Outcomes of Hydroxychloroquine Usage in United States Veterans Hospitalized with COVID-19

Med (New York, N.y.), 1

G. Matharu, S. Kunutsor, A. Judge, A. Blom, M. Whitehouse (2020)

Clinical Effectiveness and Safety of Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee Replacement: A Systematic Review and Meta-analysis of Randomized Clinical Trials.

JAMA internal medicine

(Omer SB, Malani P, Del Rio C. The COVID-19 pandemic in the US: a clinical update. JAMA 2020;323:1767–8. 10.1001/jama.2020.578832250388)

Omer SB, Malani P, Del Rio C. The COVID-19 pandemic in the US: a clinical update. JAMA 2020;323:1767–8. 10.1001/jama.2020.578832250388

Omer SB, Malani P, Del Rio C. The COVID-19 pandemic in the US: a clinical update. JAMA 2020;323:1767–8. 10.1001/jama.2020.578832250388, Omer SB, Malani P, Del Rio C. The COVID-19 pandemic in the US: a clinical update. JAMA 2020;323:1767–8. 10.1001/jama.2020.578832250388

P. Goyal, Justin Choi, L. Pinheiro, E. Schenck, Ruijun Chen, Assem Jabri, M. Satlin, T. Campion, M. Nahid, J. Ringel, K. Hoffman, M. Alshak, Han Li, G. Wehmeyer, M. Rajan, E. Reshetnyak, N. Hupert, E. Horn, F. Martinez, R. Gulick, M. Safford (2020)

Clinical Characteristics of Covid-19 in New York City

The New England Journal of Medicine

(2019)

Lebanon crisis response plan

(Scholten EL, Beitler JR, Prisk GK, et al. Treatment of ARDS with prone positioning. Chest 2017;151:215–24. 10.1016/j.chest.2016.06.03227400909)

Scholten EL, Beitler JR, Prisk GK, et al. Treatment of ARDS with prone positioning. Chest 2017;151:215–24. 10.1016/j.chest.2016.06.03227400909

Scholten EL, Beitler JR, Prisk GK, et al. Treatment of ARDS with prone positioning. Chest 2017;151:215–24. 10.1016/j.chest.2016.06.03227400909, Scholten EL, Beitler JR, Prisk GK, et al. Treatment of ARDS with prone positioning. Chest 2017;151:215–24. 10.1016/j.chest.2016.06.03227400909

(Jagan N, Morrow LE, Walters RW, et al. The positioned study: prone positioning in Nonventilated coronavirus disease 2019 Patients-A retrospective analysis. Crit Care Explor 2020;2:e0229. 10.1097/CCE.000000000000022933063033)

Jagan N, Morrow LE, Walters RW, et al. The positioned study: prone positioning in Nonventilated coronavirus disease 2019 Patients-A retrospective analysis. Crit Care Explor 2020;2:e0229. 10.1097/CCE.000000000000022933063033, Jagan N, Morrow LE, Walters RW, et al. The positioned study: prone positioning in Nonventilated coronavirus disease 2019 Patients-A retrospective analysis. Crit Care Explor 2020;2:e0229. 10.1097/CCE.000000000000022933063033

Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Practical recommendations for the prevention and management of COVID-19 in low-income and middle-income settings: adapting clinical experience from the field

Practical recommendations for the prevention and management of COVID-19 in low-income and middle-income settings: adapting clinical experience from the field